Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coreg CR vs Toprol XL on Endothelial Function in Hypertension and Diabetes
NCT00732511Phase 4Unknown
- Sponsor
- SUNY Downstate Health Sciences University
- Start
- Apr 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of carvedilol in hypertension (HTN) (2 arms), sponsored by SUNY Downstate Health Sciences University. Primary endpoints: Endothelial function at 12 weeks, Vascular compliance at 12 weeks and 1 more. Status: unknown.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00732511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732511.